» Articles » PMID: 38474094

Phenotypic Analysis of Hematopoietic Stem and Progenitor Cell Populations in Acute Myeloid Leukemia Based on Spectral Flow Cytometry, a 20-Color Panel, and Unsupervised Learning Algorithms

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Mar 13
PMID 38474094
Authors
Affiliations
Soon will be listed here.
Abstract

The analysis of hematopoietic stem and progenitor cell populations (HSPCs) is fundamental in the understanding of normal hematopoiesis as well as in the management of malignant diseases, such as leukemias, and in their diagnosis and follow-up, particularly the measurement of treatment efficiency with the detection of measurable residual disease (MRD). In this study, I designed a 20-color flow cytometry panel tailored for the comprehensive analysis of HSPCs using a spectral cytometer. My investigation encompassed the examination of forty-six samples derived from both normal human bone marrows (BMs) and patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) along with those subjected to chemotherapy and BM transplantation. By comparing my findings to those obtained through conventional flow cytometric analyses utilizing multiple tubes, I demonstrate that my innovative 20-color approach enables a more in-depth exploration of HSPC subpopulations and the detection of MRD with at least comparable sensitivity. Furthermore, leveraging advanced analytical tools such as t-SNE and FlowSOM learning algorithms, I conduct extensive cross-sample comparisons with two-dimensional gating approaches. My results underscore the efficacy of these two methods as powerful unsupervised alternatives for manual HSPC subpopulation analysis. I expect that in the future, complex multi-dimensional flow cytometric data analyses, such as those employed in this study, will be increasingly used in hematologic diagnostics.

Citing Articles

Significance of Measurable Residual Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia.

Gang M, Othus M, Walter R Cells. 2025; 14(4).

PMID: 39996762 PMC: 11853423. DOI: 10.3390/cells14040290.


Detection of Cancer Stem Cells from Patient Samples.

Hakala S, Hamalainen A, Sandelin S, Giannareas N, Narva E Cells. 2025; 14(2).

PMID: 39851576 PMC: 11764358. DOI: 10.3390/cells14020148.

References
1.
Notta F, Doulatov S, Laurenti E, Poeppl A, Jurisica I, Dick J . Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment. Science. 2011; 333(6039):218-21. DOI: 10.1126/science.1201219. View

2.
Ferrer-Font L, Pellefigues C, Mayer J, Small S, Jaimes M, Price K . Panel Design and Optimization for High-Dimensional Immunophenotyping Assays Using Spectral Flow Cytometry. Curr Protoc Cytom. 2020; 92(1):e70. DOI: 10.1002/cpcy.70. View

3.
Bonnet D, Dick J . Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997; 3(7):730-7. DOI: 10.1038/nm0797-730. View

4.
Mizuta S, Iwasaki M, Bandai N, Yoshida S, Watanabe A, Takashima H . Flow cytometric analysis of CD34 CD38 cells; cell frequency and immunophenotype based on CD45RA expression pattern. Cytometry B Clin Cytom. 2023; 106(1):35-44. DOI: 10.1002/cyto.b.22148. View

5.
Schenkel J, Hergott C, Dudley G, Drew M, Charest K, Dorfman D . Use of a Blast Dominance-Hematogone Index for the Flow Cytometric Evaluation of Myelodysplastic Syndrome (MDS). Am J Clin Pathol. 2019; 151(6):584-592. DOI: 10.1093/ajcp/aqz004. View